Neonc Technologies (NASDAQ:NTHI) CEO Acquires $70,035.93 in Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Thomas Chen bought 12,757 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was acquired at an average cost of $5.49 per share, for a total transaction of $70,035.93. Following the acquisition, the chief executive officer directly owned 13,705 shares of the company’s stock, valued at $75,240.45. The trade was a 1,345.68% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Neonc Technologies Stock Performance

Neonc Technologies stock opened at $4.68 on Friday. The stock’s fifty day moving average is $4.14 and its two-hundred day moving average is $5.95. Neonc Technologies Holdings, Inc. has a 1-year low of $3.01 and a 1-year high of $12.99.

Neonc Technologies (NASDAQ:NTHI) last released its quarterly earnings data on Monday, August 10th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.46).

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of NTHI. Bank of America Corp DE acquired a new position in Neonc Technologies in the second quarter valued at $1,017,000. BlackRock Inc. purchased a new stake in shares of Neonc Technologies in the second quarter valued at about $815,000. Global Retirement Partners LLC acquired a new stake in shares of Neonc Technologies during the second quarter worth about $126,000. Westmount Partners LLC boosted its stake in shares of Neonc Technologies by 355.2% during the second quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock worth $893,000 after buying an additional 153,858 shares during the period. Finally, 683 Capital Management LLC purchased a new position in shares of Neonc Technologies during the fourth quarter worth about $442,000.

Analyst Ratings Changes

A number of equities analysts recently issued reports on NTHI shares. BTIG Research reaffirmed a “buy” rating and issued a $15.00 price target on shares of Neonc Technologies in a report on Tuesday, May 26th. Weiss Ratings cut shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, June 24th. Maxim Group started coverage on shares of Neonc Technologies in a research report on Monday, May 18th. They set a “buy” rating and a $20.00 price objective for the company. Alliance Global Partners started coverage on shares of Neonc Technologies in a research report on Tuesday, May 19th. They set a “buy” rating and a $13.00 price objective for the company. Finally, Wall Street Zen cut shares of Neonc Technologies from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Neonc Technologies has an average rating of “Hold” and an average price target of $16.00.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.